347 related articles for article (PubMed ID: 11325798)
1. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid.
Yan JJ; Cho JY; Kim HS; Kim KL; Jung JS; Huh SO; Suh HW; Kim YH; Song DK
Br J Pharmacol; 2001 May; 133(1):89-96. PubMed ID: 11325798
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
Cho JY; Kim HS; Kim DH; Yan JJ; Suh HW; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):901-7. PubMed ID: 15970368
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of long-term administration of ferulic acid on microglial activation induced by intracerebroventricular injection of beta-amyloid peptide (1-42) in mice.
Kim HS; Cho JY; Kim DH; Yan JJ; Lee HK; Suh HW; Song DK
Biol Pharm Bull; 2004 Jan; 27(1):120-1. PubMed ID: 14709913
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Li J; Wang C; Zhang JH; Cai JM; Cao YP; Sun XJ
Brain Res; 2010 Apr; 1328():152-61. PubMed ID: 20171955
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of a dimeric derivative of ferulic acid in animal models of Alzheimer's disease.
Jung JS; Yan JJ; Li HM; Sultan MT; Yu J; Lee HS; Shin KJ; Song DK
Eur J Pharmacol; 2016 Jul; 782():30-4. PubMed ID: 27118174
[TBL] [Abstract][Full Text] [Related]
6. Anti-amnesic effect of ESP-102 on Aβ(1-42)-induced memory impairment in mice.
Kim DH; Jung WY; Park SJ; Kim JM; Lee S; Kim YC; Ryu JH
Pharmacol Biochem Behav; 2010 Dec; 97(2):239-48. PubMed ID: 20728465
[TBL] [Abstract][Full Text] [Related]
7. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice.
Yan JJ; Kim DH; Moon YS; Jung JS; Ahn EM; Baek NI; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):25-30. PubMed ID: 14687853
[TBL] [Abstract][Full Text] [Related]
8. The effects of acute and repeated oroxylin A treatments on Abeta(25-35)-induced memory impairment in mice.
Kim DH; Kim S; Jeon SJ; Son KH; Lee S; Yoon BH; Cheong JH; Ko KH; Ryu JH
Neuropharmacology; 2008 Oct; 55(5):639-47. PubMed ID: 18620712
[TBL] [Abstract][Full Text] [Related]
9. Brain toxicity and inflammation induced in vivo in mice by the amyloid-β forty-two inducer aftin-4, a roscovitine derivative.
Meunier J; Borjini N; Gillis C; Villard V; Maurice T
J Alzheimers Dis; 2015; 44(2):507-24. PubMed ID: 25298201
[TBL] [Abstract][Full Text] [Related]
10. Lack of synaptic vesicle protein SV2B protects against amyloid-β₂₅₋₃₅-induced oxidative stress, cholinergic deficit and cognitive impairment in mice.
Detrait E; Maurice T; Hanon E; Leclercq K; Lamberty Y
Behav Brain Res; 2014 Sep; 271():277-85. PubMed ID: 24937053
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
[TBL] [Abstract][Full Text] [Related]
12. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.
Maurice T; Lockhart BP; Privat A
Brain Res; 1996 Jan; 706(2):181-93. PubMed ID: 8822355
[TBL] [Abstract][Full Text] [Related]
13. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant effects of epicatechin on the hippocampal toxicity caused by amyloid-beta 25-35 in rats.
Cuevas E; Limón D; Pérez-Severiano F; Díaz A; Ortega L; Zenteno E; Guevara J
Eur J Pharmacol; 2009 Aug; 616(1-3):122-7. PubMed ID: 19540227
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
[TBL] [Abstract][Full Text] [Related]
16. Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice.
Villard V; Espallergues J; Keller E; Alkam T; Nitta A; Yamada K; Nabeshima T; Vamvakides A; Maurice T
Neuropsychopharmacology; 2009 May; 34(6):1552-66. PubMed ID: 19052542
[TBL] [Abstract][Full Text] [Related]
17. Ferulic acid supplementation prevents trimethyltin-induced cognitive deficits in mice.
Kim MJ; Choi SJ; Lim ST; Kim HK; Heo HJ; Kim EK; Jun WJ; Cho HY; Kim YJ; Shin DH
Biosci Biotechnol Biochem; 2007 Apr; 71(4):1063-8. PubMed ID: 17420591
[TBL] [Abstract][Full Text] [Related]
18. Ergothioneine protects against neuronal injury induced by β-amyloid in mice.
Yang NC; Lin HC; Wu JH; Ou HC; Chai YC; Tseng CY; Liao JW; Song TY
Food Chem Toxicol; 2012 Nov; 50(11):3902-11. PubMed ID: 22921351
[TBL] [Abstract][Full Text] [Related]
19. The effects of Betula platyphylla bark on amyloid beta-induced learning and memory impairment in mice.
Cho N; Lee HK; Jeon BJ; Kim HW; Kim HP; Lee JH; Kim YC; Sung SH
Food Chem Toxicol; 2014 Dec; 74():156-63. PubMed ID: 25301235
[TBL] [Abstract][Full Text] [Related]
20. PPARγ agonist pioglitazone improves scopolamine-induced memory impairment in mice.
Xiang GQ; Tang SS; Jiang LY; Hong H; Li Q; Wang C; Wang XY; Zhang TT; Yin L
J Pharm Pharmacol; 2012 Apr; 64(4):589-96. PubMed ID: 22420664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
